RORA, a transcription factor, exacerbates age-related cataract by targeting the prion protein (PRNP) and triggering oxidative stress-induced senescence and apoptosis in lens epithelial cells. Inhibiting RORA or blocking the RORA-PRNP axis restores cellular resilience and may offer a therapeutic target for cataract prevention and reversal.
Key Points
- RORA targeting PRNP drives oxidative damage and cellular senescence in lens cells
- RORA inhibition restores anti-apoptotic capacity and oxidative stress resistance
- RORA-PRNP-p53/p21/Bax pathway identifies dual therapeutic intervention point
Longevity Analysis
Cataracts represent a measurable decline in visual function and quality of life during aging. This research identifies a specific molecular switch—the RORA-PRNP interaction—that governs whether lens cells accumulate damage or repair themselves under oxidative stress. By targeting this pathway, interventions could intercept the senescence and cell death that blur vision rather than merely managing the end result. The finding extends beyond ocular disease: RORA and PRNP are expressed throughout the body, suggesting this mechanism may be relevant to broader age-related tissue degeneration wherever oxidative stress accumulates.
Original published by Wiley Aging Cell, by Yue Zou, Wanqian Li, Jiaojiao Zhang, Chao Cen, Wanqiu Zheng, Ruonan Li, Hong Cheng, Liang Liang, Juan Kang, Wenjuan Wan, Ke Hu, Shijie Zheng .